Top Suppliers:I want be here

125602-71-3

125602-71-3 structure
125602-71-3 structure
  • Name: (S)-Bepotastine
  • Chemical Name: bepotastine
  • CAS Number: 125602-71-3
  • Molecular Formula: C21H25ClN2O3
  • Molecular Weight: 388.888
  • Catalog: Signaling Pathways GPCR/G Protein Histamine Receptor
  • Create Date: 2018-02-28 08:00:00
  • Modify Date: 2024-01-03 21:29:52
  • Bepotastine is an orally active second-generation histamine H1 receptor antagonist. Bepotastine has the potential for allergic rhinitis and urticaria/pruritus treatment[1][2].

Name bepotastine
Synonyms (+)-(S)-4-[4-[(4-chlorophenyl)(2-pyridyl)methoxy]piperidino]butyric acid monobenzenesulfonate
4-[(S)-(4-chlorophenyl)-2-pyridinylMethoxy]
4-{4-[(S)-(4-Chlorophenyl)(2-pyridinyl)methoxy]-1-piperidinyl}butanoic acid
(+)-(S)-4-{4[(4-chlorphenyl)(2-pyridil)methoxy]piperidino}butyric acid monobenzenesulfonate
1-Piperidinebutanoic acid, 4-[(S)-(4-chlorophenyl)-2-pyridinylmethoxy]-
1-Piperidinebutanoic acid,4-[(S)-(4-chlorophenyl)-2-pyridinylmethoxy]
4-[4-[(4-Chlorophenyl)pyridin-2-ylmethoxy]piperidin-1-yl]butanoic acid
(+)-(S)-4-[4-[1-(4-chlorophenyl)-1-(2-pyridyl)methoxy]piperidin-1-yl]butyric acid
[14C]-Bepotastine besilate
Bepotastine
4-(4-[(1S)(4-CHLOROPHENYL)-2-PYRIDYLMETHOXY]PIPERIDYL)BUTANOIC ACID
betotastine besilate
4-(4-((S)-(4-Chlorophenyl)(pyridin-2-yl)methoxy)piperidin-1-yl)butanoic Acid
(+)-4-(((S)-p-Chloro-2-pyridylbenzyl)oxy)-1-piperidinebutyric Acid
betotastine
Bepreve
4-{4-[(S)-(4-Chlorophenyl)(pyridin-2-yl)methoxy]piperidin-1-yl}butanoic acid
Density 1.3±0.1 g/cm3
Boiling Point 546.8±50.0 °C at 760 mmHg
Melting Point 56-58 °C
Molecular Formula C21H25ClN2O3
Molecular Weight 388.888
Flash Point 284.5±30.1 °C
Exact Mass 388.155365
PSA 62.66000
LogP 3.67
Vapour Pressure 0.0±1.5 mmHg at 25°C
Index of Refraction 1.605
Hazard Codes Xn
125602-71-3 structure

125602-71-3

~64%

125602-71-3 structure

125602-71-3

Literature: Ha, Tae Hee; Suh, Kwee-Hyun; Lee, Gwan Sun Bulletin of the Korean Chemical Society, 2013 , vol. 34, # 2 p. 549 - 552
125602-71-3 structure

125602-71-3

~68%

125602-71-3 structure

125602-71-3

Literature: Hanmi Pharm. Co., Ltd. Patent: US2010/137367 A1, 2010 ; Location in patent: Page/Page column 3 ;

~%

125602-71-3 structure

125602-71-3

Literature: US2014/46068 A1, ;

~%

125602-71-3 structure

125602-71-3

Literature: US2014/46068 A1, ;

~%

125602-71-3 structure

125602-71-3

Literature: US2014/46068 A1, ;